title: Reply to P. Baldo et al.
authors.affiliation: Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione G.Pascale IRCCS, Naples, Italy f.perrone@istitutotumori.na.it.
authors.forename: Francesco
authors.initials: F
authors.lastname: Perrone
authors.affiliation: Università degli Studi di Torino, Torino, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Di Maio
authors.affiliation: Seconda Università di Napoli, Naples, Italy.
authors.forename: Ciro
authors.initials: C
authors.lastname: Gallo
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male
chemical_list: D000970:Antineoplastic Agents